Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Microsoft brings its AI network to cardiology

Also launches cloud-based genomics service for its Azure platform

Microsoft artificial intelligence AI cloud computing

Microsoft has expanded its healthcare artificial intelligence offering beyond eyecare to target cardiology.

Launched last year as the Microsoft Intelligent Network for Eyecare (MINE), the work initially aimed to tackle visions problems through a collaboration with academic institutions in India, Brazil, Australia and the US.

The newly-renamed AI Network for Healthcare will now also be used to create an AI-focused network in cardiology, work that will initially see it partner with Apollo Hospitals, one of India’s largest health systems.

The IT giant has also launched a cloud-based genomics service to provide researchers and clinicians with ‘highly accelerated, cloud-powered genomic processing services’.

That launch, which will use Microsoft’s Azure cloud computing platform, will see it partner with the Tennessee-based St Jude Children’s Research Hospital.

Peter Lee, corporate VP at Microsoft AI + Research, said: “By working side-by-side with the healthcare industry’s most pioneering players, we are bringing Microsoft’s capabilities in ground-breaking research and product development to help healthcare providers, biotech companies and organisations around the world use artificial intelligence (AI) and the cloud to innovate.”

Both initiatives are part of Microsoft’s Healthcare NExT initiative, which aims to accelerate healthcare innovation through artificial intelligence and cloud computing.

Earlier this year Microsoft teamed up with Seattle-based sequencing company Adaptive Biotechnologies to map the genetics of the human immune system, using a combination of machine learning and cloud computing technologies.

The company also recently started working with Shire to look at how technology could be used to accelerate the time it takes to diagnose rare diseases in children.

2nd March 2018

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....

Infographics